Population pharmacokinetics of doxycycline in the tears and plasma of northern elephant seals (Mirounga angustirostris) following oral drug administration

Journal of the American Veterinary Medical Association

Volumn 243, Issue 8, 2013, Pages 1170-1178

  Freeman, Kate S ^a   Thomasy, Sara M ^b   Stanley, Scott D ^a   Van Bonn, William ^c   Gulland, Frances ^c   Friedlaender, Ari S ^d,e   Maggs, David J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THE MARINE MAMMAL CENTER   (United States)

^d DUKE UNIVERSITY MARINE LABORATORY   (United States)

^e Ophthalmology for Animals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; FEMALE; HALF LIFE TIME; LACRIMAL FLUID; MALE; ORAL DRUG ADMINISTRATION; PHOCA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DOXYCYCLINE; FEMALE; HALF-LIFE; MALE; SEALS, EARLESS; TEARS;

EID: 84885124723     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.243.8.1170     Document Type: Article

References (38)

1. Colitz CMH, Renner MS, Manire CA, et al. Characterization of "sea lion keratitis" in captive Zalophus californianus. Vet Oph-thalmol 2010;12:390-409.
2. Solomon A, Rosenblatt M, Li DQ, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 2000;41:2544-2557.
3. Baker A, Plummer CE, Szabo NJ, et al. Doxycycline levels in preocular tear film of horses following oral administration. Vet Ophthalmol 2008;11:381-385.
4. Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Oph-thalmol 2005;19:258-263.
5. Castro LJ, Sahagun AM, Diez MJ, et al. Pharmacokinetics of doxycycline in sheep after intravenous and oral administration. Vet J 2009;180:380-395.
6. Plumb DC. Plumb's veterinary drug handbook. 7th ed. Ames, Iowa: Wiley-Blackwell Publishing, 2011;1187.
7. Dunn JL, Buck JD, Robeck TR. Bacterial diseases of cetaceans and pinnipeds. In: Dierauf LA, Gulland FMD, eds. CRC handbook of marine mammal medicine. 2nd ed. Boca Raton, Fla: CRC Press Inc, 2001;314.
8. Colegrove KM, Lowenstine LJ, Gulland FM. Leptospirosis in northern elephant seals (Mirounga angustirostris) stranded along the California coast. J Wild Dis 2005;41:426-430.
9. Kik MJ, Goris MG, Bos JH, et al. An outbreak of leptospirosis in seals (Phoca vitulina) in captivity. Vet Q 2006;28:33-39.
10. Hunt TD, Ziccardi MH, Gulland FM, et al. Health risks for marine mammal workers. Dis Aquat Organ 2008;19:81-92.
11. Harms CA, Maggi RG, Breitschwerdt EB, et al. Bartonella species detection in captive, stranded and free-ranging cetaceans. Vet Res 2008;39:59.
12. Association for Research in Vision and Ophthalmology website. Statement for the use of animals in ophthalmic and visual research. Available at: www.arvo.org/About_ARVO/Policies/ Statement_for_the_Use_of_Animals_in_Ophthalmic_and_ Visual_Research/. Accessed Dec 5, 2009.
13. Thomasy SM, Covert JC, Stanley SD, et al. Pharmacokinetics of famciclovir and penciclovir in tears following oral administration of famciclovir to cats: a pilot study. Vet Ophthalmol 2012;15:299-306.
14. Yang S, Cha J, Carlson K. Simultaneous extraction and analysis of 11 tetracycline and sulfonamide antibiotics in influent and effluent domestic wastewater by solid-phase extraction and liquid chromatography-electrospray ionization tandem mass spec-trometry. J Chromatogr A 2005;1097:40-53.
15. Laczay P, Semjen G, Lehel J, et al. Pharmacokinetics and bio-availability of doxycycline in fasted and nonfasted broiler chickens. Acta Vet Hung 2001;49:31-37.
16. Davis JL, Salmon JH, Papich MG. Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. Am J Vet Res 2006;67:310-316.
17. Toutain PL, Bousquet-Mélou A. Volumes of distribution. J Vet Pharmacol Ther 2004;27:441-453.
18. Hartmann A, Krebber R, Dauve G, et al. Pharmacokinetics of pra-dofloxacin and doxycycline in serum, saliva and tear fluid in cats after oral administration. J Vet Pharmacol Ther 2008;31:87-94.
19. Riond JL, Vaden SL, Riviere JE. Comparative pharmacoki-netics of doxycycline in cats and dogs. J Vet Pharmacol Ther 1990;13:415-424.
20. Waller GH, Harrison RJ. The significance of eyelid glands in delphinids. Aquat Mamm 1978;6:1-9.
21. Gulland FMD, Haulena M, Dierauf LA. Seals and sea lions. In: Dierauf LA, Gulland FMD, eds. CRC handbook of marine mammal medicine. 2nd ed. Boca Raton, Fla: CRC Press Inc, 2001;920.
22. Nazir SA, Murphy S, Siatkowski RM, et al. Ocular rosacea in childhood. Am J Ophthalmol 2004;137:138-144.
23. Thornton SM, Nolan S, Gulland FM. Bacterial isolates from California sea lions (Zalophus californianus), harbor seals (Phoca vitulina), and northern elephant seals (Mirounga angustirostris) admitted to a rehabilitation center along the central California coast, 1994-1995. J Zoo Wildl Med 1998;29:171-176.
24. You IC, Ahn M, Yoon K W, et al. A case of Vibrio vulnificus kera-titis. Jpn J Ophthalmol 2008;52:131-133.
25. Egwu GO, Aliyu MM. Inhibitory and mycoplasmacidal concentrations of some antibiotic on strains of Mycoplasma mycoides subsp. mycoides SC: the causative agent of contagious bovine pleuropneumoniae. Acta Vet (Beograd) 1998;48:309-316.
26. Firsov AA, Vostrov SN, Lubenko IY, et al. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. Int J Antimicrob Agents 2004;23:451-456.
27. Ross JE, Jones RN, Quality Control Working Group. MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methods. Diagn Microbiol Infect Dis 2004;50:295-297.
28. Brook I, Elliott TB, Pryor HI, et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents 2001;18:559-562.
29. Zhanel GG, Palatnick L, Nichol KA, et al. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003;47:1867-1874.
30. Pudjiatmoko H, Fukushi H, Ochiai Y, et al. In vitro susceptibility of Chlamydia pecorum to macrolides, tetracyclines, quino-lones and beta-lactam. Microbiol Immunol 1998;42:61-63.
31. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
32. Lee J, Wormser G P. Pharmacodynamics of doxycycline for che-moprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials. Int J Antimicrob Agents 2008;31:235-239.
33. KuKanich B, Huff D, Riviere JE, et al. Naïve averaged, naïve pooled, and population pharmacokinetics of orally administered marbofloxacin in juvenile harbor seals. J Am Vet Med Assoc 2007;230:390-395.
34. Sykes JE, Hartmann K, Lunn K F, et al. 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med 2011;25:1-13.
35. Papich MG. Saunders handbook of veterinary drugs. 2nd ed. St Louis: Saunders Elsevier, 2007;858.
36. Smith VA, Khan-Lim D, Anderson L, et al. Does orally administered doxycycline reach the tear film? Br J Ophthalmol 2008;92:856-859.
37. Federici TJ. The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease. Pharmacol Res 2011;64:614-623.
38. Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011;63:130-145.